Login

Ampio Pharmaceuticals, Inc. SEC Filings

Filed On Filing
29 Jan 2025 8-K: Other Events

Plaintiff: JORDAN LEAJAMES (MCCANN), Derivatively on Behalf of AMPIO

15 Apr 2024 15-12G
04 Apr 2024 FORM 25
27 Mar 2024 10-K
25 Mar 2024 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events

ENGLEWOOD, Colo., March 25, 2024 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”) today announced that its Board of Directors determined to voluntarily delist its common stock from the NYSE American and dere...

04 Mar 2024 EFFECT
28 Feb 2024 8-K: Termination of a Material Definitive Agreement

On February 26, 2024, Ampio Pharmaceuticals, Inc. (the “Company”) provided a notice to H.C. Wainwright & Co., LLC to terminate that certain At The Marketing Offering Agreement, dated September 18, 2023, by and between the Company and H.C...

28 Feb 2024 S-8 POS
28 Feb 2024 S-8 POS
28 Feb 2024 POS AM
28 Feb 2024 RW
15 Feb 2024 8-K: Regulation FD Disclosure

ENGLEWOOD, Colo., February 14, 2024 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part ...

25 Jan 2024 8-K: Other Events

We have acted as legal counsel to Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), in connection with the transactions contemplated by that certain At The Market Offering Agreement, dated as of September 18, 2023 (the...

25 Jan 2024 424B5
24 Jan 2024 424B5
11 Jan 2024 8-K: Regulation FD Disclosure

ENGLEWOOD, Colo., January 11, 2024 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part o...

21 Dec 2023 S-1
07 Dec 2023 SC 13G/A
14 Nov 2023 10-Q
02 Nov 2023 8-K: Regulation FD Disclosure

Ampio Pharmaceuticals 1 Emerging Growth Conference November 02, 2023 iStock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support